|
1
|
Kapoor VK: Gallbladder cancer: A global
perspective. J Surg Oncol. 93:607–609. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Wu XS, Shi LB, Li ML, Ding Q, Weng H, Wu
WG, Cao Y, Bao RF, Shu YJ, Ding QC, et al: Evaluation of two
inflammation-based prognostic scores in patients with resectable
gallbladder carcinoma. Ann Surg Oncol. 21:449–457. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhu AX, Hong TS, Hezel AF and Kooby DA:
Current management of gallbladder carcinoma. Oncologist.
15:168–181. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wakai T, Shirai Y, Yokoyama N, Nagakura S,
Watanabe H and Hatakeyama K: Early gallbladder carcinoma does not
warrant radical resection. Br J Surg. 88:675–678. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Yang GF, He WP, Cai MY, He LR, Luo JH,
Deng HX, Guan XY, Zeng MS, Zeng YX and Xie D: Intensive expression
of Bmi-1 is a new independent predictor of poor outcome in patients
with ovarian carcinoma. BMC Cancer. 10:1332010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
He XT, Cao XF, Ji L, Zhu B, Lv J, Wang DD,
Lu PH and Cui HG: Association between Bmi1 and clinicopathological
status of esophageal squamous cell carcinoma. World J
Gastroenterol. 15:2389–2394. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Luo M, Shen D-X, Guo X-T, Guan T and Chen
X-D: Clinicopathological and prognostic significance of Bmi-1
expression in human cervical cancer. Acta Obstet Gynecol Scand.
90:737–745. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lazcano-Ponce EC, Miquel JF, Muñoz N,
Herrero R, Ferrecio C, Wistuba II, Alonso de Ruiz P, Aristi Urista
G and Nervi F: Epidemiology and molecular pathology of gallbladder
cancer. CA Cancer J Clin. 51:349–364. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pandey M: Risk factors for gallbladder
cancer: A reappraisal. Eur J Cancer Prev. 12:15–24. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nandakumar A, Gupta PC, Gangadharan P,
Visweswara RN and Parkin DM: Geographic pathology revisited:
Development of an atlas of cancer in India. Int J Cancer.
116:740–754. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Misra S, Chaturvedi A, Misra NC and Sharma
ID: Carcinoma of the gallbladder. Lancet Oncol. 4:167–176. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsing AW, Gao YT, Devesa SS, Jin F and
Fraumeni JF Jr: Rising incidence of biliary tract cancers in
Shanghai, China. Int J Cancer. 75:368–370. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ito H, Matros E, Brooks DC, Osteen RT,
Zinner MJ, Swanson RS, Ashley SW and Whang EE: Treatment outcomes
associated with surgery for gallbladder cancer: A 20-year
experience. J Gastrointest Surg. 8:183–190. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qin L, Zhang X, Zhang L, Feng Y, Weng GX,
Li MZ, Kong QL, Qian CN, Zeng YX, Zeng MS, et al: Downregulation of
BMI-1 enhances 5-fluorouracil-induced apoptosis in nasopharyngeal
carcinoma cells. Biochem Biophys Res Commun. 371:531–535. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Becker M, Korn C, Sienerth AR, Voswinckel
R, Luetkenhaus K, Ceteci F and Rapp UR: Polycomb group protein Bmi1
is required for growth of RAF driven non-small-cell lung cancer.
PLoS One. 4:e42302009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Xiao J and Deng C: Knockdown of Bmi-1
impairs growth and invasiveness of human gastric carcinoma cells.
Oncol Res. 17:613–620. 2009. View Article : Google Scholar : PubMed/NCBI
|
